Data Insights
                                    By  Company Name
                                
                                No Filter Selected
                                    By  Disease Name
                                
                                No Filter Selected
                                    By  Drug Name
                                
                                No Filter Selected
                                    By Themes
                                
                                No Filter Selected
                                    Showing 1 results out of 1                                
                                
                                                Data Insights
                                                
                                        Larsucosterol sodium by DURECT for Alcoholic Hepatitis: Likelihood of Approval
Larsucosterol sodium is under clinical development by DURECT and currently in Phase II for Alcoholic Hepatitis. According to GlobalData, Phase...
